Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Human Vaccines & Immunotherapeutics
|
November 27, 2014
Cost-effectiveness of vaccination against herpes zoster
Pieter T de Boer, Jan C Wilschut, Maarten J Postma
Ebiomedicine
|
December 3, 2015
The 'Dynamic' Marriage Between Varicella and Zoster
Pieter T de Boer, Jan C Wilschut, Maarten J Postma
Influenza and Other Respiratory Viruses
|
August 11, 2015
Retrospective public health impact of a quadrivalent influenza vaccine in the United States
Pascal Crépey, Pieter T de Boer, Maarten J Postma, et al.
BMC Medicine
|
January 15, 2020
Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes
Pieter T de Boer, Jantien A Backer, Albert Jan van Hoek, et al.
Pharmacoeconomics
|
May 1, 2016
Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer
Pieter T de Boer, Geert W J Frederix, Talitha L Feenstra, et al.
Vaccines
|
February 5, 2021
Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review
Tanja Fens, Pieter T de Boer, Eugène P van Puijenbroek, et al.
Journal of Bone and Mineral Metabolism
|
April 12, 2013
Persistence with osteoporosis medication among newly-treated osteoporotic patients
Job F M van Boven, Pieter T de Boer, Maarten J Postma, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
May 25, 2017
The Effect of Individual Movements and Interventions on the Spread of Influenza in Long-Term Care Facilities
Mehdi Najafi, Marek Laskowski, Pieter T de Boer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 19, 2016
Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States
Pieter T de Boer, Pascal Crépey, Richard J Pitman, et al.
BMC Infectious Diseases
|
February 1, 2013
An update of "Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model"
Hong Anh T Tu, Mark H Rozenbaum, Pieter T de Boer, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Human Vaccines & Immunotherapeutics
|
November 27, 2014
Cost-effectiveness of vaccination against herpes zoster
Pieter T de Boer, Jan C Wilschut, Maarten J Postma
Ebiomedicine
|
December 3, 2015
The 'Dynamic' Marriage Between Varicella and Zoster
Pieter T de Boer, Jan C Wilschut, Maarten J Postma
Influenza and Other Respiratory Viruses
|
August 11, 2015
Retrospective public health impact of a quadrivalent influenza vaccine in the United States
Pascal Crépey, Pieter T de Boer, Maarten J Postma, et al.
BMC Medicine
|
January 15, 2020
Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes
Pieter T de Boer, Jantien A Backer, Albert Jan van Hoek, et al.
Pharmacoeconomics
|
May 1, 2016
Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer
Pieter T de Boer, Geert W J Frederix, Talitha L Feenstra, et al.
Vaccines
|
February 5, 2021
Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review
Tanja Fens, Pieter T de Boer, Eugène P van Puijenbroek, et al.
Journal of Bone and Mineral Metabolism
|
April 12, 2013
Persistence with osteoporosis medication among newly-treated osteoporotic patients
Job F M van Boven, Pieter T de Boer, Maarten J Postma, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
May 25, 2017
The Effect of Individual Movements and Interventions on the Spread of Influenza in Long-Term Care Facilities
Mehdi Najafi, Marek Laskowski, Pieter T de Boer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 19, 2016
Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States
Pieter T de Boer, Pascal Crépey, Richard J Pitman, et al.
BMC Infectious Diseases
|
February 1, 2013
An update of "Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model"
Hong Anh T Tu, Mark H Rozenbaum, Pieter T de Boer, et al.
Page
of 3